dicycloverine ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
spasmolytics with a papaverine-like action 868 77-19-0

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • dicymine
  • dicycloverine hydrochloride
  • dicycloverine
  • dicyclomine
  • dicycloverin
  • dicyclomine hydrochloride
  • dicyclomine HCl
A muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms.
  • Molecular weight: 309.49
  • Formula: C19H35NO2
  • CLOGP: 6.14
  • LIPINSKI: 1
  • HAC: 3
  • HDO: 0
  • TPSA: 29.54
  • ALOGS: -4.98
  • ROTB: 8

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
80 mg O
80 mg P

ADMET properties:

PropertyValueReference
MRTD (Maximum Recommended Therapeutic Daily Dose) 4.30 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
S (Water solubility) 50 mg/mL Bocci G, Oprea TI, Benet LZ
BDDCS (Biopharmaceutical Drug Disposition Classification System) 1 Bocci G, Oprea TI, Benet LZ

Approvals:

DateAgencyCompanyOrphan
May 11, 1950 FDA FOREST LABS INC

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Cholecystitis chronic 201.81 12.41 97 28600 10264 63450061
Biliary dyskinesia 107.43 12.41 42 28655 2687 63457638
Anxiety 92.58 12.41 261 28436 217280 63243045
Abdominal pain 82.96 12.41 306 28391 293150 63167175
Gallbladder disorder 81.85 12.41 68 28629 18774 63441551
Contraindicated product administered 81.72 12.41 4 28693 217644 63242681
Synovitis 65.46 12.41 5 28692 186913 63273412
Maternal exposure during pregnancy 64.38 12.41 11 28686 220051 63240274
Glossodynia 59.35 12.41 6 28691 178870 63281455
Drug intolerance 56.31 12.41 35 28662 308626 63151699
Diarrhoea 51.09 12.41 520 28177 714846 62745479
Rhinalgia 50.48 12.41 21 28676 1578 63458747
Drug ineffective 50.33 12.41 273 28424 1044492 62415833
Vulvovaginal burning sensation 48.02 12.41 22 28675 2087 63458238
Treatment failure 46.43 12.41 16 28681 199027 63261298
Depression 45.02 12.41 192 28505 196300 63264025
Vulvovaginal pruritus 41.80 12.41 23 28674 3220 63457105
Product dose omission issue 41.24 12.41 212 28485 234101 63226224
Arthropathy 39.61 12.41 29 28668 234763 63225562
General physical health deterioration 39.32 12.41 21 28676 201381 63258944
Abdominal pain upper 38.58 12.41 190 28507 206254 63254071
Systemic lupus erythematosus 37.64 12.41 24 28673 208894 63251431
Cholelithiasis 36.85 12.41 69 28628 43856 63416469
Gallbladder injury 36.07 12.41 16 28681 1407 63458918
Rheumatoid arthritis 35.96 12.41 37 28660 253782 63206543
Nausea 35.95 12.41 563 28134 853908 62606417
Wound 34.96 12.41 15 28682 163248 63297077
Joint swelling 33.13 12.41 61 28636 327605 63132720
Paranasal sinus discomfort 32.98 12.41 22 28675 4354 63455971
Colitis ulcerative 32.61 12.41 49 28648 26042 63434283
Emotional distress 32.27 12.41 55 28642 32494 63427831
Urinary tract infection 32.01 12.41 217 28480 264467 63195858
Abdominal pain lower 30.36 12.41 47 28650 25631 63434694
Therapeutic product effect decreased 29.89 12.41 26 28671 193161 63267164
Surgery 29.61 12.41 56 28641 35856 63424469
Helicobacter infection 28.56 12.41 4 28693 92781 63367544
Migraine 28.46 12.41 107 28590 103239 63357086
Therapy partial responder 27.88 12.41 29 28668 10629 63449696
Diverticulitis 26.99 12.41 57 28640 39500 63420825
Hepatic enzyme increased 26.98 12.41 31 28666 202297 63258028
Biliary colic 26.82 12.41 18 28679 3599 63456726
Gallbladder hypofunction 26.71 12.41 10 28687 568 63459757
Abdominal distension 26.66 12.41 93 28604 86522 63373803
Pre-existing condition improved 26.32 12.41 25 28672 8219 63452106
Constipation 25.75 12.41 182 28515 224761 63235564
Intestinal obstruction 25.25 12.41 48 28649 30851 63429474
Nasal dryness 25.19 12.41 19 28678 4562 63455763
Fungal infection 25.00 12.41 53 28644 36821 63423504
Palpitations 24.88 12.41 109 28588 112661 63347664
Flatulence 24.84 12.41 51 28646 34651 63425674
Chest pain 24.30 12.41 174 28523 215785 63244540
Increased appetite 23.06 12.41 25 28672 9605 63450720
Thrombocytopenia 22.59 12.41 21 28676 151136 63309189
Infusion site pruritus 22.58 12.41 20 28677 6015 63454310
Nasal discomfort 22.39 12.41 18 28679 4742 63455583
Infusion site erythema 22.35 12.41 27 28670 11652 63448673
Alopecia 22.33 12.41 78 28619 337458 63122867
Small intestinal obstruction 22.29 12.41 34 28663 18303 63442022
Poor peripheral circulation 21.62 12.41 16 28681 3733 63456592
Injection site extravasation 21.26 12.41 23 28674 8818 63451507
Neutropenia 21.05 12.41 29 28668 174976 63285349
Stress 19.71 12.41 71 28626 67096 63393229
Muscle injury 19.69 12.41 3 28694 65342 63394983
Folliculitis 19.51 12.41 4 28693 70313 63390012
Muscle spasms 19.44 12.41 129 28568 156021 63304304
Cholecystectomy 19.33 12.41 24 28673 10653 63449672
Scleritis 19.26 12.41 16 28681 4412 63455913
Suicidal ideation 19.19 12.41 67 28630 62354 63397971
Bronchitis 18.55 12.41 108 28589 124827 63335498
Exposure during pregnancy 18.48 12.41 26 28671 155521 63304804
C-reactive protein increased 18.29 12.41 10 28687 94697 63365628
Vascular access site pain 18.20 12.41 5 28692 103 63460222
Headache 18.02 12.41 393 28304 632848 62827477
Clostridium difficile infection 18.01 12.41 41 28656 29881 63430444
Pancytopenia 17.63 12.41 11 28686 96922 63363403
Colitis 17.51 12.41 55 28642 48473 63411852
Psychological trauma 17.40 12.41 9 28688 1112 63459213
Anhedonia 17.25 12.41 23 28674 10951 63449374
Sinus congestion 17.14 12.41 30 28667 18093 63442232
Impaired gastric emptying 16.77 12.41 22 28675 10310 63450015
Weight decreased 16.74 12.41 195 28502 276603 63183722
Upper-airway cough syndrome 16.54 12.41 23 28674 11395 63448930
Pancreatitis 16.26 12.41 54 28643 49001 63411324
Illness 16.25 12.41 54 28643 49005 63411320
Interstitial lung disease 16.21 12.41 4 28693 61904 63398421
Neck pain 16.05 12.41 68 28629 69250 63391075
Chronic sinusitis 15.88 12.41 24 28673 12819 63447506
Nasal congestion 15.66 12.41 65 28632 65595 63394730
Injury 15.54 12.41 70 28627 73177 63387148
Haematochezia 15.20 12.41 56 28641 53488 63406837
Irritable bowel syndrome 14.76 12.41 75 28622 82337 63377988
Pain 14.68 12.41 438 28259 740190 62720135
Vitamin D deficiency 14.46 12.41 24 28673 13868 63446457
Cholesterosis 14.45 12.41 6 28691 449 63459876
Aphthous ulcer 14.41 12.41 24 28673 13914 63446411
Somnambulism 14.35 12.41 15 28682 5528 63454797
Hypoaesthesia 14.18 12.41 127 28570 168266 63292059
Crying 14.06 12.41 32 28665 23311 63437014
Tonsillitis fungal 13.88 12.41 3 28694 21 63460304
Intestinal mucosal hypertrophy 13.83 12.41 5 28692 257 63460068
Intervertebral disc degeneration 13.55 12.41 25 28672 15707 63444618
Back pain 13.35 12.41 180 28517 263965 63196360
Vision blurred 13.34 12.41 79 28618 91845 63368480
Blister 13.24 12.41 24 28673 129790 63330535
Hyponatraemia 12.99 12.41 19 28678 111881 63348444
Oropharyngeal pain 12.94 12.41 80 28617 94407 63365918
Infusion related reaction 12.92 12.41 62 28635 245459 63214866
Febrile neutropenia 12.90 12.41 21 28676 118428 63341897
Diabetic neuropathy 12.61 12.41 12 28685 3952 63456373

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Irritable bowel syndrome 33.13 15.56 15 6060 3628 34947228
Diarrhoea 31.28 15.56 142 5933 389770 34561086
Abdominal pain 29.35 15.56 78 5997 163540 34787316
Hypogonadism 26.08 15.56 11 6064 2244 34948612
Alkalosis hypochloraemic 21.93 15.56 6 6069 326 34950530
Aplastic anaemia 21.69 15.56 16 6059 9700 34941156
Colitis ulcerative 19.80 15.56 19 6056 16501 34934355
Nausea 18.31 15.56 111 5964 339797 34611059
Apathy 16.80 15.56 12 6063 6920 34943936
Rectourethral fistula 16.39 15.56 3 6072 24 34950832
Intestinal obstruction 16.35 15.56 20 6055 22802 34928054
Weight decreased 16.17 15.56 67 6008 176234 34774622

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Cholecystitis chronic 199.26 12.75 86 26024 9820 79708458
Biliary dyskinesia 108.02 12.75 38 26072 2507 79715771
Gallbladder disorder 88.13 12.75 63 26047 19277 79699001
Abdominal pain 82.98 12.75 298 25812 389271 79329007
Anxiety 73.67 12.75 213 25897 248299 79469979
Vulvovaginal burning sensation 60.53 12.75 22 26088 1595 79716683
Diarrhoea 58.99 12.75 490 25620 879999 78838279
Rhinalgia 52.39 12.75 22 26088 2345 79715933
Vulvovaginal pruritus 46.92 12.75 21 26089 2612 79715666
Product dose omission issue 44.06 12.75 179 25931 247358 79470920
Abdominal pain upper 44.00 12.75 167 25943 223652 79494626
Gallbladder injury 39.78 12.75 15 26095 1206 79717072
Paranasal sinus discomfort 39.16 12.75 22 26088 4434 79713844
Pain 38.45 12.75 375 25735 703427 79014851
Colitis ulcerative 38.44 12.75 52 26058 34690 79683588
Synovitis 37.99 12.75 3 26107 150731 79567547
Nausea 37.27 12.75 477 25633 956719 78761559
General physical health deterioration 34.45 12.75 24 26086 275214 79443064
Abdominal pain lower 34.30 12.75 47 26063 31735 79686543
Neutropenia 33.55 12.75 27 26083 287683 79430595
Cholelithiasis 32.09 12.75 60 26050 52604 79665674
Drug intolerance 31.79 12.75 24 26086 264095 79454183
Clostridium difficile infection 31.65 12.75 53 26057 42632 79675646
Emotional distress 31.49 12.75 51 26059 39918 79678360
Urinary tract infection 30.30 12.75 173 25937 274339 79443939
Headache 29.84 12.75 336 25774 653436 79064842
Nasal dryness 28.30 12.75 18 26092 4545 79713733
Migraine 27.83 12.75 77 26033 87416 79630862
Diverticulitis 27.57 12.75 52 26058 45884 79672394
Irritable bowel syndrome 27.40 12.75 62 26048 62179 79656099
Injection site extravasation 25.78 12.75 23 26087 9646 79708632
Nasal discomfort 25.29 12.75 18 26092 5465 79712813
Chest pain 24.92 12.75 168 25942 282136 79436142
Depression 24.82 12.75 138 25972 216652 79501626
Surgery 24.71 12.75 41 26069 32725 79685553
Cholecystectomy 24.29 12.75 22 26088 9410 79708868
Upper-airway cough syndrome 23.89 12.75 24 26086 11669 79706609
Palpitations 23.65 12.75 93 26017 126517 79591761
Increased appetite 23.41 12.75 24 26086 11954 79706324
Neck pain 22.64 12.75 65 26045 75352 79642926
Gallbladder hypofunction 22.57 12.75 8 26102 539 79717739
Vision blurred 22.44 12.75 81 26029 105817 79612461
Hypogonadism 22.02 12.75 11 26099 1749 79716529
Interstitial lung disease 21.90 12.75 5 26105 112595 79605683
Small intestinal obstruction 21.75 12.75 35 26075 27237 79691041
Drug interaction 21.63 12.75 67 26043 415116 79303162
Flatulence 21.59 12.75 45 26065 42679 79675599
Pericarditis 21.57 12.75 4 26106 104232 79614046
Thrombocytopenia 21.02 12.75 34 26076 265225 79453053
Pain in extremity 20.69 12.75 196 25914 364342 79353936
Injury 20.61 12.75 64 26046 77432 79640846
Biliary colic 20.60 12.75 14 26096 3948 79714330
Drug ineffective 20.56 12.75 241 25869 1080672 78637606
Multiple organ dysfunction syndrome 20.30 12.75 7 26103 120239 79598039
Intestinal obstruction 20.22 12.75 44 26066 42976 79675302
Abdominal distension 20.06 12.75 85 26025 119565 79598713
Treatment failure 19.86 12.75 16 26094 170470 79547808
Maternal exposure during pregnancy 19.75 12.75 10 26100 136528 79581750
Pancreatitis 19.52 12.75 58 26052 68517 79649761
Constipation 19.05 12.75 158 25952 282892 79435386
Bronchitis 19.02 12.75 89 26021 130555 79587723
Hyperkalaemia 18.73 12.75 7 26103 114391 79603887
Cardiac failure 18.71 12.75 14 26096 154828 79563450
Vascular access site pain 18.69 12.75 5 26105 130 79718148
Parotitis 18.42 12.75 11 26099 2483 79715795
Chronic sinusitis 18.36 12.75 22 26088 13004 79705274
Aphthous ulcer 18.26 12.75 25 26085 16864 79701414
Psychological trauma 18.22 12.75 9 26101 1397 79716881
Sinus congestion 17.91 12.75 27 26083 19869 79698409
Infusion site pruritus 17.81 12.75 13 26097 4105 79714173
Glossodynia 17.47 12.75 6 26104 103331 79614947
Nasal congestion 17.46 12.75 60 26050 76492 79641786
Oropharyngeal pain 17.04 12.75 76 26034 109277 79609001
Fungal infection 16.63 12.75 40 26070 41708 79676570
Injection site pain 16.44 12.75 85 26025 129753 79588525
Crying 16.27 12.75 28 26082 23015 79695263
Stress 16.11 12.75 60 26050 79552 79638726
Pancreatitis acute 16.11 12.75 44 26066 49560 79668718
Proctalgia 15.95 12.75 18 26092 9983 79708295
Alkalosis hypochloraemic 15.73 12.75 6 26104 498 79717780
Impaired gastric emptying 15.45 12.75 18 26092 10335 79707943
Joint dislocation 15.27 12.75 23 26087 16916 79701362
Discharge 15.05 12.75 8 26102 1446 79716832
Illness 14.85 12.75 41 26069 46470 79671808
Tonsillitis fungal 14.84 12.75 3 26107 21 79718257
Presbyopia 14.73 12.75 6 26104 592 79717686
Colitis 14.63 12.75 55 26055 73252 79645026
Back pain 14.58 12.75 158 25952 304022 79414256
Pre-existing condition improved 14.37 12.75 13 26097 5550 79712728
Muscle spasms 14.23 12.75 102 26008 174628 79543650
Oral herpes 13.96 12.75 29 26081 27425 79690853
Intestinal mucosal hypertrophy 13.95 12.75 5 26105 348 79717930
Hip fracture 13.93 12.75 31 26079 30730 79687548
Hepatic enzyme increased 13.91 12.75 24 26086 182586 79535692
Helicobacter infection 13.74 12.75 3 26107 69701 79648577
Rheumatoid arthritis 13.62 12.75 30 26080 208440 79509838
Suicidal ideation 13.39 12.75 55 26055 76285 79641993
Pancytopenia 13.35 12.75 21 26089 165724 79552554
Increased upper airway secretion 13.30 12.75 11 26099 4166 79714112
Anhedonia 13.10 12.75 20 26090 14878 79703400
Device issue 13.05 12.75 28 26082 27080 79691198
C-reactive protein increased 12.80 12.75 14 26096 129013 79589265

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A03AA07 ALIMENTARY TRACT AND METABOLISM
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
Synthetic anticholinergics, esters with tertiary amino group
FDA MoA N0000175370 Cholinergic Antagonists
FDA EPC N0000175574 Anticholinergic
CHEBI has role CHEBI:48876 muscarinic antagonists
CHEBI has role CHEBI:50370 parasympatholytics
CHEBI has role CHEBI:53784 antispasmodics
MeSH PA D018678 Cholinergic Agents
MeSH PA D018680 Cholinergic Antagonists
MeSH PA D018727 Muscarinic Antagonists
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D010276 Parasympatholytics
MeSH PA D018373 Peripheral Nervous System Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Irritable bowel syndrome indication 10743008 DOID:9778
Calculus in biliary tract off-label use 266474003
Brain damage contraindication 2470005
Tachyarrhythmia contraindication 6285003
Suicidal thoughts contraindication 6471006
Urinary tract obstruction contraindication 7163005 DOID:5200
Alcoholism contraindication 7200002
Hyperammonemia contraindication 9360008
Hepatic encephalopathy contraindication 13920009 DOID:13413
Severe chronic ulcerative colitis contraindication 14311001
Toxic megacolon contraindication 28536002 DOID:1770
Atony of colon contraindication 29479008
Hyperthyroidism contraindication 34486009 DOID:7998
Depressive disorder contraindication 35489007
Hypertensive disorder contraindication 38341003 DOID:10763
Complete trisomy 21 syndrome contraindication 41040004 DOID:14250
Achalasia of esophagus contraindication 45564002 DOID:9164
Chronic heart failure contraindication 48447003
Paralytic ileus contraindication 55525008 DOID:8442
Peptic reflux disease contraindication 57643001
Hepatic failure contraindication 59927004
Ulcerative colitis contraindication 64766004 DOID:8577
Poisoning by phenobarbital contraindication 64921004
Drug AND/OR toxin-induced diarrhea contraindication 65979008
Substance abuse contraindication 66214007
Hepatic coma contraindication 72836002 DOID:12550
Sleep apnea contraindication 73430006 DOID:0050847
Spastic paralysis contraindication 78403003
Disturbance of salivary secretion contraindication 78948009
Kidney disease contraindication 90708001 DOID:557
Myasthenia gravis contraindication 91637004 DOID:437
Gastrointestinal obstruction contraindication 126765001
Autonomic dysreflexia contraindication 129618003
Bleeding contraindication 131148009
Disease of liver contraindication 235856003 DOID:409
Bladder outflow obstruction contraindication 236645006
Benign prostatic hyperplasia contraindication 266569009
Dyspnea contraindication 267036007
Retention of urine contraindication 267064002
Anemia contraindication 271737000 DOID:2355
Pregnancy, function contraindication 289908002
Thrombocytopenic disorder contraindication 302215000 DOID:1588
Neutropenic disorder contraindication 303011007 DOID:1227
Angle-closure glaucoma contraindication 392291006 DOID:13550
Gastric ulcer contraindication 397825006 DOID:10808
Breastfeeding (mother) contraindication 413712001
Chronic lung disease contraindication 413839001
Disorder of coronary artery contraindication 414024009
Porphyria contraindication 418470004
Fever greater than 100.4 Fahrenheit contraindication 426000000




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 8.41 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Muscarinic acetylcholine receptor M3 GPCR ANTAGONIST Ki 9.03 DRUG MATRIX CHEMBL
Muscarinic acetylcholine receptor M1 GPCR ANTAGONIST Ki 9.08 DRUG MATRIX CHEMBL
5-hydroxytryptamine receptor 2A GPCR Ki 7.16 DRUG MATRIX
5-hydroxytryptamine receptor 2B GPCR Ki 6.08 DRUG MATRIX
5-hydroxytryptamine receptor 2C GPCR Ki 6.61 DRUG MATRIX
5-hydroxytryptamine receptor 6 GPCR Ki 5.85 DRUG MATRIX
D(3) dopamine receptor GPCR Ki 6.39 DRUG MATRIX
Histamine H2 receptor GPCR Ki 5.80 DRUG MATRIX
Muscarinic acetylcholine receptor M2 GPCR ANTAGONIST Ki 6.60 IUPHAR
Muscarinic acetylcholine receptor M4 GPCR Ki 9.39 DRUG MATRIX
Muscarinic acetylcholine receptor M5 GPCR Ki 8.77 DRUG MATRIX
Sigma non-opioid intracellular receptor 1 Membrane receptor Ki 8.69 DRUG MATRIX
Sodium channel alpha subunits; brain (Types I, II, III) Ion channel IC50 4.55 CHEMBL
Potassium voltage-gated channel subfamily H member 2 Ion channel Ki 4.77 DRUG MATRIX
Membrane-associated progesterone receptor component 1 Membrane receptor IC50 6.33 DRUG MATRIX
SMR1-alpha2 Unclassified Ki 6.54 DRUG MATRIX
Muscarinic acetylcholine receptor M2 GPCR Ki 7.33 CHEMBL
Muscarinic acetylcholine receptor M1 GPCR Ki 8.61 CHEMBL

External reference:

IDSource
4017870 VUID
N0000179550 NUI
D00717 KEGG_DRUG
67-92-5 SECONDARY_CAS_RN
152021 RXNORM
4017870 VANDF
4019716 VANDF
C0012125 UMLSCUI
CHEBI:4514 CHEBI
CHEMBL1123 ChEMBL_ID
CHEMBL1200479 ChEMBL_ID
DB00804 DRUGBANK_ID
355 IUPHAR_LIGAND_ID
3042 PUBCHEM_CID
158 MMSL
4587 MMSL
d00999 MMSL
001758 NDDF
004711 NDDF
372732007 SNOMEDCT_US
41493007 SNOMEDCT_US
71043005 SNOMEDCT_US
D004025 MESH_DESCRIPTOR_UI
619 INN_ID
4KV4X8IF6V UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0054-0622 SOLUTION 10 mg ORAL ANDA 24 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0054-0622 SOLUTION 10 mg ORAL ANDA 24 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0054-0748 CAPSULE 10 mg ORAL ANDA 25 sections
Dicyclomine HUMAN PRESCRIPTION DRUG LABEL 1 0143-1227 TABLET 20 mg ORAL ANDA 26 sections
Dicyclomine HUMAN PRESCRIPTION DRUG LABEL 1 0143-1227 TABLET 20 mg ORAL ANDA 26 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0143-3126 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0143-3126 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0378-1610 CAPSULE 10 mg ORAL ANDA 27 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0378-1610 CAPSULE 10 mg ORAL ANDA 27 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0378-1620 TABLET 20 mg ORAL ANDA 27 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0378-1620 TABLET 20 mg ORAL ANDA 27 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0440-7384 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0517-1980 INJECTION, SOLUTION 20 mg INTRAMUSCULAR ANDA 24 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0517-1980 INJECTION, SOLUTION 20 mg INTRAMUSCULAR ANDA 24 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0527-0586 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0527-1282 TABLET 20 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0591-0794 CAPSULE 10 mg ORAL ANDA 25 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0591-0795 TABLET 20 mg ORAL ANDA 25 sections
dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0603-1161 SOLUTION 10 mg ORAL ANDA 26 sections
Dicyclomine HUMAN PRESCRIPTION DRUG LABEL 1 0615-0327 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine HUMAN PRESCRIPTION DRUG LABEL 1 0615-0327 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0615-8483 CAPSULE 10 mg ORAL ANDA 25 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0641-6173 INJECTION 10 mg INTRAMUSCULAR ANDA 25 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0641-6173 INJECTION 10 mg INTRAMUSCULAR ANDA 25 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0832-6052 TABLET 20 mg ORAL ANDA 30 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0832-6053 CAPSULE 10 mg ORAL ANDA 30 sections
Dicyclomine hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0904-6969 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0904-6987 CAPSULE 10 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0904-6988 TABLET 20 mg ORAL ANDA 26 sections
Dicyclomine Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 10135-520 CAPSULE 10 mg ORAL ANDA 25 sections